 xipamid disposit liver cirrhosi pharmacokinet sulfonamide-typ diuret xipamid patient liver cirrhosi ascit healthi control subject oral administr mg diuret blood ascit ratio area concentration-tim curv auc plasma ascit fluid protein content respect compart auc plasma cirrhot patient control subject strike find increas amount Ae parent drug main metabolit urin renal clearanc xipamid patient liver cirrhosi auc Ae plasma concentr direct bilirubin patient nonren drug clearanc patient liver cirrhosi result blockad hepatobiliari excret cholestat condit